The Genomic Landscape of Mucinous Breast Cancer

Author:

Pareja Fresia1,Lee Ju Youn1,Brown David N1,Piscuoglio Salvatore12,Gularte-Mérida Rodrigo1,Selenica Pier1,Da Cruz Paula Arnaud1,Arunachalam Sasi1,Kumar Rahul1,Geyer Felipe C1,Silveira Catarina13,da Silva Edaise M1,Li Anqi1,Marchiò Caterina4,Ng Charlotte K Y12,Mariani Odette5,Fuhrmann Laetitia5,Wen Hannah Y1,Norton Larry6,Vincent-Salomon Anne5,Brogi Edi1,Reis-Filho Jorge S1,Weigelt Britta1

Affiliation:

1. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY

2. Institute of Pathology, University Hospital Basel, Basel, Switzerland

3. GenoMed SA, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal

4. Department of Medical Sciences, FPO-Canndiolo Cancer Institute, University of Turin, Turin, Italy

5. Départment de Médecine Diagnostique et Théranostique, Institute Curie, Paris, France

6. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Abstract

Abstract Mucinous carcinoma of the breast (MCB) is a rare histologic form of estrogen receptor (ER)-positive/HER2-negative breast cancer (BC) characterized by tumor cells floating in lakes of mucin. We assessed the genomic landscape of 32 MCBs by whole-exome sequencing and/or RNA-sequencing. GATA3 (23.8%), KMT2C (19.0%), and MAP3K1 (14.3%) were the most frequently mutated genes in pure MCBs. In addition, two recurrent but not pathognomonic fusion genes, OAZ1-CSNK1G2 and RFC4-LPP, were detected in 3/31 (9.7%) and 2/31 (6.5%) samples, respectively. Compared with ER-positive/HER2-negative common forms of BC, MCBs displayed lower PIK3CA and TP53 mutation rates and fewer concurrent 1q gains and 16q losses. Clonal decomposition analysis of the mucinous and ductal components independently microdissected from five mixed MCBs revealed that they are clonally related and evolve following clonal selection or parallel evolution. Our findings indicate that MCB represents a genetically distinct ER-positive/HER2-negative form of BC.

Funder

National Cancer Institute

National Institutes of Health

Susan G. Komen Research and Training

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Cited by 67 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3